SCHEMBL29767945

SCHEMBL29767945

COc1ccccc1C(=O)n1nc(N)c2ccc(C3[C@@H](C)[C@H]3C)nc21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX15 P16050 2/20 0.49
▸ HSD17B10 Q99714 2/20 0.49
▸ MAPT P10636 7/20 0.46
▸ SMN1; SMN2 Q16637 4/20 0.46
▸ HTT P42858 4/20 0.46
▸ TP53 P04637 2/20 0.46
▸ PKM P14618 1/20 0.46
▸ POLB P06746 4/20 0.46
▸ F2 P00734 6/20 0.45
▸ F12 P00748 2/20 0.44
▸ TTR P02766 1/20 0.43
▸ GAA P10253 2/20 0.42
▸ MGAM O43451 1/20 0.42
▸ AMY1A P0DUB6 1/20 0.42
▸ MIF P14174 1/20 0.42
▸ SI P14410 1/20 0.42
▸ MGAM2 Q2M2H8 1/20 0.42
▸ KLKB1 P03952 5/20 0.41
▸ F10 P00742 2/20 0.41
▸ ALDH1A1 P00352 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26834621 1.00 ALOX15 (0.49) ALOX15HSD17B10MAPTSMN1; SMN2HTT
SCHEMBL26834610 0.89 ALOX15 (0.47) ALOX15HSD17B10MAPTSMN1; SMN2HTT
SCHEMBL29767952 0.89 ALOX15 (0.47) ALOX15HSD17B10MAPTSMN1; SMN2HTT
SCHEMBL26675344 0.89 ALOX15 (0.47) ALOX15HSD17B10MAPTSMN1; SMN2HTT
SCHEMBL26675432 0.88 ALOX15 (0.48) ALOX15HSD17B10MAPTSMN1; SMN2HTT
SCHEMBL30600508 0.86 ALOX15 (0.47) ALOX15HSD17B10MAPTSMN1; SMN2HTT
SCHEMBL26675308 0.86 ALOX15 (0.47) ALOX15HSD17B10MAPTSMN1; SMN2HTT
SCHEMBL30675610 0.85 ALOX15 (0.46) ALOX15HSD17B10MAPTSMN1; SMN2HTT
SCHEMBL29767956 0.85 ALOX15 (0.46) ALOX15HSD17B10MAPTSMN1; SMN2HTT
SCHEMBL26675362 0.85 ALOX15 (0.46) ALOX15HSD17B10MAPTSMN1; SMN2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12630549-B2 Pyrazoleamide derivatives HOFFMANN-LA ROCHE INC. (US) 2026-05-19 — — US claimed
EP-4284797-A1 PYRAZOLEAMIDE DERIVATIVES F. Hoffmann-La Roche AG (CH) 2023-12-06 — — EP claimed
US-20230382911-A1 PYRAZOLEAMIDE DERIVATIVES HOFFMANN-LA ROCHE INC. (US) 2023-11-30 — — US claimed
CN-116867782-A Pyrazole amide derivative 豪夫迈·罗氏有限公司 2023-10-10 — — CN claimed
WO-2022162034-A1 PYRAZOLEAMIDE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2022-08-04 — — WO claimed
US-12630549-B2 Pyrazoleamide derivatives HOFFMANN-LA ROCHE INC. (US) 2026-05-19 — — US disclosed
EP-4284797-A1 PYRAZOLEAMIDE DERIVATIVES F. Hoffmann-La Roche AG (CH) 2023-12-06 — — EP disclosed
US-20230382911-A1 PYRAZOLEAMIDE DERIVATIVES HOFFMANN-LA ROCHE INC. (US) 2023-11-30 — — US disclosed
CN-116867782-A Pyrazole amide derivative 豪夫迈·罗氏有限公司 2023-10-10 — — CN disclosed
WO-2022162034-A1 PYRAZOLEAMIDE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2022-08-04 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230382911-A1 PYRAZOLEAMIDE DERIVATIVES P2RY1, P2RX1, P2RX5 ALOX15 3863/4885HSD17B10 2897/4885MAPT 3058/4885
US-12630549-B2 Pyrazoleamide derivatives CYP11B2, CYP11B1, ADRA1B ALOX15 3315/4885HSD17B10 882/4885MAPT 2409/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback